Global Poliomyelitis Vaccines Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2024.
LPI (LP Information)' newest research report, the “Poliomyelitis Vaccines Industry Forecast” looks at past sales and reviews total world Poliomyelitis Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Poliomyelitis Vaccines sales for 2023 through 2029. With Poliomyelitis Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Poliomyelitis Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Poliomyelitis Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Poliomyelitis Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Poliomyelitis Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Poliomyelitis Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Poliomyelitis Vaccines.
The global Poliomyelitis Vaccines market size is projected to grow from US$ 694.4 million in 2022 to US$ 819 million in 2029; it is expected to grow at a CAGR of 819 from 2023 to 2029.
Sanofi, GSK and Serum Institute are the top 3 players of Polio Vaccine with about 99% market shares.
This report presents a comprehensive overview, market shares, and growth opportunities of Poliomyelitis Vaccines market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Poliomyelitis Vaccines market?
What factors are driving Poliomyelitis Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Poliomyelitis Vaccines market opportunities vary by end market size?
How does Poliomyelitis Vaccines break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2024.
LPI (LP Information)' newest research report, the “Poliomyelitis Vaccines Industry Forecast” looks at past sales and reviews total world Poliomyelitis Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Poliomyelitis Vaccines sales for 2023 through 2029. With Poliomyelitis Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Poliomyelitis Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Poliomyelitis Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Poliomyelitis Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Poliomyelitis Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Poliomyelitis Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Poliomyelitis Vaccines.
The global Poliomyelitis Vaccines market size is projected to grow from US$ 694.4 million in 2022 to US$ 819 million in 2029; it is expected to grow at a CAGR of 819 from 2023 to 2029.
Sanofi, GSK and Serum Institute are the top 3 players of Polio Vaccine with about 99% market shares.
This report presents a comprehensive overview, market shares, and growth opportunities of Poliomyelitis Vaccines market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- IPV
- OPV
- Research & Academic Laboratories
- Pharmaceutical & Biotechnology Companies
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi
- GSK
- Bibcol
- Serum Institute
- Tiantan Biological
- IMBCA
- Panacea Biotec Ltd
- Bio-Med
- Halfkin Bio-Pharmaceuticals
What is the 10-year outlook for the global Poliomyelitis Vaccines market?
What factors are driving Poliomyelitis Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Poliomyelitis Vaccines market opportunities vary by end market size?
How does Poliomyelitis Vaccines break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Poliomyelitis Vaccines Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Poliomyelitis Vaccines by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Poliomyelitis Vaccines by Country/Region, 2018, 2022 & 2029
2.2 Poliomyelitis Vaccines Segment by Type
2.2.1 IPV
2.2.2 OPV
2.3 Poliomyelitis Vaccines Sales by Type
2.3.1 Global Poliomyelitis Vaccines Sales Market Share by Type (2018-2023)
2.3.2 Global Poliomyelitis Vaccines Revenue and Market Share by Type (2018-2023)
2.3.3 Global Poliomyelitis Vaccines Sale Price by Type (2018-2023)
2.4 Poliomyelitis Vaccines Segment by Application
2.4.1 Research & Academic Laboratories
2.4.2 Pharmaceutical & Biotechnology Companies
2.4.3 Others
2.5 Poliomyelitis Vaccines Sales by Application
2.5.1 Global Poliomyelitis Vaccines Sale Market Share by Application (2018-2023)
2.5.2 Global Poliomyelitis Vaccines Revenue and Market Share by Application (2018-2023)
2.5.3 Global Poliomyelitis Vaccines Sale Price by Application (2018-2023)
3 GLOBAL POLIOMYELITIS VACCINES BY COMPANY
3.1 Global Poliomyelitis Vaccines Breakdown Data by Company
3.1.1 Global Poliomyelitis Vaccines Annual Sales by Company (2018-2023)
3.1.2 Global Poliomyelitis Vaccines Sales Market Share by Company (2018-2023)
3.2 Global Poliomyelitis Vaccines Annual Revenue by Company (2018-2023)
3.2.1 Global Poliomyelitis Vaccines Revenue by Company (2018-2023)
3.2.2 Global Poliomyelitis Vaccines Revenue Market Share by Company (2018-2023)
3.3 Global Poliomyelitis Vaccines Sale Price by Company
3.4 Key Manufacturers Poliomyelitis Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Poliomyelitis Vaccines Product Location Distribution
3.4.2 Players Poliomyelitis Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR POLIOMYELITIS VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Poliomyelitis Vaccines Market Size by Geographic Region (2018-2023)
4.1.1 Global Poliomyelitis Vaccines Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Poliomyelitis Vaccines Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Poliomyelitis Vaccines Market Size by Country/Region (2018-2023)
4.2.1 Global Poliomyelitis Vaccines Annual Sales by Country/Region (2018-2023)
4.2.2 Global Poliomyelitis Vaccines Annual Revenue by Country/Region (2018-2023)
4.3 Americas Poliomyelitis Vaccines Sales Growth
4.4 APAC Poliomyelitis Vaccines Sales Growth
4.5 Europe Poliomyelitis Vaccines Sales Growth
4.6 Middle East & Africa Poliomyelitis Vaccines Sales Growth
5 AMERICAS
5.1 Americas Poliomyelitis Vaccines Sales by Country
5.1.1 Americas Poliomyelitis Vaccines Sales by Country (2018-2023)
5.1.2 Americas Poliomyelitis Vaccines Revenue by Country (2018-2023)
5.2 Americas Poliomyelitis Vaccines Sales by Type
5.3 Americas Poliomyelitis Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Poliomyelitis Vaccines Sales by Region
6.1.1 APAC Poliomyelitis Vaccines Sales by Region (2018-2023)
6.1.2 APAC Poliomyelitis Vaccines Revenue by Region (2018-2023)
6.2 APAC Poliomyelitis Vaccines Sales by Type
6.3 APAC Poliomyelitis Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Poliomyelitis Vaccines by Country
7.1.1 Europe Poliomyelitis Vaccines Sales by Country (2018-2023)
7.1.2 Europe Poliomyelitis Vaccines Revenue by Country (2018-2023)
7.2 Europe Poliomyelitis Vaccines Sales by Type
7.3 Europe Poliomyelitis Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Poliomyelitis Vaccines by Country
8.1.1 Middle East & Africa Poliomyelitis Vaccines Sales by Country (2018-2023)
8.1.2 Middle East & Africa Poliomyelitis Vaccines Revenue by Country (2018-2023)
8.2 Middle East & Africa Poliomyelitis Vaccines Sales by Type
8.3 Middle East & Africa Poliomyelitis Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Poliomyelitis Vaccines
10.3 Manufacturing Process Analysis of Poliomyelitis Vaccines
10.4 Industry Chain Structure of Poliomyelitis Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Poliomyelitis Vaccines Distributors
11.3 Poliomyelitis Vaccines Customer
12 WORLD FORECAST REVIEW FOR POLIOMYELITIS VACCINES BY GEOGRAPHIC REGION
12.1 Global Poliomyelitis Vaccines Market Size Forecast by Region
12.1.1 Global Poliomyelitis Vaccines Forecast by Region (2024-2029)
12.1.2 Global Poliomyelitis Vaccines Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Poliomyelitis Vaccines Forecast by Type
12.7 Global Poliomyelitis Vaccines Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Poliomyelitis Vaccines Product Portfolios and Specifications
13.1.3 Sanofi Poliomyelitis Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Poliomyelitis Vaccines Product Portfolios and Specifications
13.2.3 GSK Poliomyelitis Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Bibcol
13.3.1 Bibcol Company Information
13.3.2 Bibcol Poliomyelitis Vaccines Product Portfolios and Specifications
13.3.3 Bibcol Poliomyelitis Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Bibcol Main Business Overview
13.3.5 Bibcol Latest Developments
13.4 Serum Institute
13.4.1 Serum Institute Company Information
13.4.2 Serum Institute Poliomyelitis Vaccines Product Portfolios and Specifications
13.4.3 Serum Institute Poliomyelitis Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Serum Institute Main Business Overview
13.4.5 Serum Institute Latest Developments
13.5 Tiantan Biological
13.5.1 Tiantan Biological Company Information
13.5.2 Tiantan Biological Poliomyelitis Vaccines Product Portfolios and Specifications
13.5.3 Tiantan Biological Poliomyelitis Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Tiantan Biological Main Business Overview
13.5.5 Tiantan Biological Latest Developments
13.6 IMBCA
13.6.1 IMBCA Company Information
13.6.2 IMBCA Poliomyelitis Vaccines Product Portfolios and Specifications
13.6.3 IMBCA Poliomyelitis Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 IMBCA Main Business Overview
13.6.5 IMBCA Latest Developments
13.7 Panacea Biotec Ltd
13.7.1 Panacea Biotec Ltd Company Information
13.7.2 Panacea Biotec Ltd Poliomyelitis Vaccines Product Portfolios and Specifications
13.7.3 Panacea Biotec Ltd Poliomyelitis Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Panacea Biotec Ltd Main Business Overview
13.7.5 Panacea Biotec Ltd Latest Developments
13.8 Bio-Med
13.8.1 Bio-Med Company Information
13.8.2 Bio-Med Poliomyelitis Vaccines Product Portfolios and Specifications
13.8.3 Bio-Med Poliomyelitis Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Bio-Med Main Business Overview
13.8.5 Bio-Med Latest Developments
13.9 Halfkin Bio-Pharmaceuticals
13.9.1 Halfkin Bio-Pharmaceuticals Company Information
13.9.2 Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Product Portfolios and Specifications
13.9.3 Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Halfkin Bio-Pharmaceuticals Main Business Overview
13.9.5 Halfkin Bio-Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Poliomyelitis Vaccines Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Poliomyelitis Vaccines by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Poliomyelitis Vaccines by Country/Region, 2018, 2022 & 2029
2.2 Poliomyelitis Vaccines Segment by Type
2.2.1 IPV
2.2.2 OPV
2.3 Poliomyelitis Vaccines Sales by Type
2.3.1 Global Poliomyelitis Vaccines Sales Market Share by Type (2018-2023)
2.3.2 Global Poliomyelitis Vaccines Revenue and Market Share by Type (2018-2023)
2.3.3 Global Poliomyelitis Vaccines Sale Price by Type (2018-2023)
2.4 Poliomyelitis Vaccines Segment by Application
2.4.1 Research & Academic Laboratories
2.4.2 Pharmaceutical & Biotechnology Companies
2.4.3 Others
2.5 Poliomyelitis Vaccines Sales by Application
2.5.1 Global Poliomyelitis Vaccines Sale Market Share by Application (2018-2023)
2.5.2 Global Poliomyelitis Vaccines Revenue and Market Share by Application (2018-2023)
2.5.3 Global Poliomyelitis Vaccines Sale Price by Application (2018-2023)
3 GLOBAL POLIOMYELITIS VACCINES BY COMPANY
3.1 Global Poliomyelitis Vaccines Breakdown Data by Company
3.1.1 Global Poliomyelitis Vaccines Annual Sales by Company (2018-2023)
3.1.2 Global Poliomyelitis Vaccines Sales Market Share by Company (2018-2023)
3.2 Global Poliomyelitis Vaccines Annual Revenue by Company (2018-2023)
3.2.1 Global Poliomyelitis Vaccines Revenue by Company (2018-2023)
3.2.2 Global Poliomyelitis Vaccines Revenue Market Share by Company (2018-2023)
3.3 Global Poliomyelitis Vaccines Sale Price by Company
3.4 Key Manufacturers Poliomyelitis Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Poliomyelitis Vaccines Product Location Distribution
3.4.2 Players Poliomyelitis Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR POLIOMYELITIS VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Poliomyelitis Vaccines Market Size by Geographic Region (2018-2023)
4.1.1 Global Poliomyelitis Vaccines Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Poliomyelitis Vaccines Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Poliomyelitis Vaccines Market Size by Country/Region (2018-2023)
4.2.1 Global Poliomyelitis Vaccines Annual Sales by Country/Region (2018-2023)
4.2.2 Global Poliomyelitis Vaccines Annual Revenue by Country/Region (2018-2023)
4.3 Americas Poliomyelitis Vaccines Sales Growth
4.4 APAC Poliomyelitis Vaccines Sales Growth
4.5 Europe Poliomyelitis Vaccines Sales Growth
4.6 Middle East & Africa Poliomyelitis Vaccines Sales Growth
5 AMERICAS
5.1 Americas Poliomyelitis Vaccines Sales by Country
5.1.1 Americas Poliomyelitis Vaccines Sales by Country (2018-2023)
5.1.2 Americas Poliomyelitis Vaccines Revenue by Country (2018-2023)
5.2 Americas Poliomyelitis Vaccines Sales by Type
5.3 Americas Poliomyelitis Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Poliomyelitis Vaccines Sales by Region
6.1.1 APAC Poliomyelitis Vaccines Sales by Region (2018-2023)
6.1.2 APAC Poliomyelitis Vaccines Revenue by Region (2018-2023)
6.2 APAC Poliomyelitis Vaccines Sales by Type
6.3 APAC Poliomyelitis Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Poliomyelitis Vaccines by Country
7.1.1 Europe Poliomyelitis Vaccines Sales by Country (2018-2023)
7.1.2 Europe Poliomyelitis Vaccines Revenue by Country (2018-2023)
7.2 Europe Poliomyelitis Vaccines Sales by Type
7.3 Europe Poliomyelitis Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Poliomyelitis Vaccines by Country
8.1.1 Middle East & Africa Poliomyelitis Vaccines Sales by Country (2018-2023)
8.1.2 Middle East & Africa Poliomyelitis Vaccines Revenue by Country (2018-2023)
8.2 Middle East & Africa Poliomyelitis Vaccines Sales by Type
8.3 Middle East & Africa Poliomyelitis Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Poliomyelitis Vaccines
10.3 Manufacturing Process Analysis of Poliomyelitis Vaccines
10.4 Industry Chain Structure of Poliomyelitis Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Poliomyelitis Vaccines Distributors
11.3 Poliomyelitis Vaccines Customer
12 WORLD FORECAST REVIEW FOR POLIOMYELITIS VACCINES BY GEOGRAPHIC REGION
12.1 Global Poliomyelitis Vaccines Market Size Forecast by Region
12.1.1 Global Poliomyelitis Vaccines Forecast by Region (2024-2029)
12.1.2 Global Poliomyelitis Vaccines Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Poliomyelitis Vaccines Forecast by Type
12.7 Global Poliomyelitis Vaccines Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Poliomyelitis Vaccines Product Portfolios and Specifications
13.1.3 Sanofi Poliomyelitis Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Poliomyelitis Vaccines Product Portfolios and Specifications
13.2.3 GSK Poliomyelitis Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Bibcol
13.3.1 Bibcol Company Information
13.3.2 Bibcol Poliomyelitis Vaccines Product Portfolios and Specifications
13.3.3 Bibcol Poliomyelitis Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Bibcol Main Business Overview
13.3.5 Bibcol Latest Developments
13.4 Serum Institute
13.4.1 Serum Institute Company Information
13.4.2 Serum Institute Poliomyelitis Vaccines Product Portfolios and Specifications
13.4.3 Serum Institute Poliomyelitis Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Serum Institute Main Business Overview
13.4.5 Serum Institute Latest Developments
13.5 Tiantan Biological
13.5.1 Tiantan Biological Company Information
13.5.2 Tiantan Biological Poliomyelitis Vaccines Product Portfolios and Specifications
13.5.3 Tiantan Biological Poliomyelitis Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Tiantan Biological Main Business Overview
13.5.5 Tiantan Biological Latest Developments
13.6 IMBCA
13.6.1 IMBCA Company Information
13.6.2 IMBCA Poliomyelitis Vaccines Product Portfolios and Specifications
13.6.3 IMBCA Poliomyelitis Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 IMBCA Main Business Overview
13.6.5 IMBCA Latest Developments
13.7 Panacea Biotec Ltd
13.7.1 Panacea Biotec Ltd Company Information
13.7.2 Panacea Biotec Ltd Poliomyelitis Vaccines Product Portfolios and Specifications
13.7.3 Panacea Biotec Ltd Poliomyelitis Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Panacea Biotec Ltd Main Business Overview
13.7.5 Panacea Biotec Ltd Latest Developments
13.8 Bio-Med
13.8.1 Bio-Med Company Information
13.8.2 Bio-Med Poliomyelitis Vaccines Product Portfolios and Specifications
13.8.3 Bio-Med Poliomyelitis Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Bio-Med Main Business Overview
13.8.5 Bio-Med Latest Developments
13.9 Halfkin Bio-Pharmaceuticals
13.9.1 Halfkin Bio-Pharmaceuticals Company Information
13.9.2 Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Product Portfolios and Specifications
13.9.3 Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Halfkin Bio-Pharmaceuticals Main Business Overview
13.9.5 Halfkin Bio-Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Poliomyelitis Vaccines Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Poliomyelitis Vaccines Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of IPV
Table 4. Major Players of OPV
Table 5. Global Poliomyelitis Vaccines Sales by Type (2018-2023) & (K Units)
Table 6. Global Poliomyelitis Vaccines Sales Market Share by Type (2018-2023)
Table 7. Global Poliomyelitis Vaccines Revenue by Type (2018-2023) & ($ million)
Table 8. Global Poliomyelitis Vaccines Revenue Market Share by Type (2018-2023)
Table 9. Global Poliomyelitis Vaccines Sale Price by Type (2018-2023) & (USD/Unit)
Table 10. Global Poliomyelitis Vaccines Sales by Application (2018-2023) & (K Units)
Table 11. Global Poliomyelitis Vaccines Sales Market Share by Application (2018-2023)
Table 12. Global Poliomyelitis Vaccines Revenue by Application (2018-2023)
Table 13. Global Poliomyelitis Vaccines Revenue Market Share by Application (2018-2023)
Table 14. Global Poliomyelitis Vaccines Sale Price by Application (2018-2023) & (USD/Unit)
Table 15. Global Poliomyelitis Vaccines Sales by Company (2018-2023) & (K Units)
Table 16. Global Poliomyelitis Vaccines Sales Market Share by Company (2018-2023)
Table 17. Global Poliomyelitis Vaccines Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Poliomyelitis Vaccines Revenue Market Share by Company (2018-2023)
Table 19. Global Poliomyelitis Vaccines Sale Price by Company (2018-2023) & (USD/Unit)
Table 20. Key Manufacturers Poliomyelitis Vaccines Producing Area Distribution and Sales Area
Table 21. Players Poliomyelitis Vaccines Products Offered
Table 22. Poliomyelitis Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Poliomyelitis Vaccines Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Poliomyelitis Vaccines Sales Market Share Geographic Region (2018-2023)
Table 27. Global Poliomyelitis Vaccines Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Poliomyelitis Vaccines Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Poliomyelitis Vaccines Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Poliomyelitis Vaccines Sales Market Share by Country/Region (2018-2023)
Table 31. Global Poliomyelitis Vaccines Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Poliomyelitis Vaccines Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Poliomyelitis Vaccines Sales by Country (2018-2023) & (K Units)
Table 34. Americas Poliomyelitis Vaccines Sales Market Share by Country (2018-2023)
Table 35. Americas Poliomyelitis Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Poliomyelitis Vaccines Revenue Market Share by Country (2018-2023)
Table 37. Americas Poliomyelitis Vaccines Sales by Type (2018-2023) & (K Units)
Table 38. Americas Poliomyelitis Vaccines Sales by Application (2018-2023) & (K Units)
Table 39. APAC Poliomyelitis Vaccines Sales by Region (2018-2023) & (K Units)
Table 40. APAC Poliomyelitis Vaccines Sales Market Share by Region (2018-2023)
Table 41. APAC Poliomyelitis Vaccines Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Poliomyelitis Vaccines Revenue Market Share by Region (2018-2023)
Table 43. APAC Poliomyelitis Vaccines Sales by Type (2018-2023) & (K Units)
Table 44. APAC Poliomyelitis Vaccines Sales by Application (2018-2023) & (K Units)
Table 45. Europe Poliomyelitis Vaccines Sales by Country (2018-2023) & (K Units)
Table 46. Europe Poliomyelitis Vaccines Sales Market Share by Country (2018-2023)
Table 47. Europe Poliomyelitis Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Poliomyelitis Vaccines Revenue Market Share by Country (2018-2023)
Table 49. Europe Poliomyelitis Vaccines Sales by Type (2018-2023) & (K Units)
Table 50. Europe Poliomyelitis Vaccines Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Poliomyelitis Vaccines Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Poliomyelitis Vaccines Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Poliomyelitis Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Poliomyelitis Vaccines Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Poliomyelitis Vaccines Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Poliomyelitis Vaccines Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Poliomyelitis Vaccines
Table 58. Key Market Challenges & Risks of Poliomyelitis Vaccines
Table 59. Key Industry Trends of Poliomyelitis Vaccines
Table 60. Poliomyelitis Vaccines Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Poliomyelitis Vaccines Distributors List
Table 63. Poliomyelitis Vaccines Customer List
Table 64. Global Poliomyelitis Vaccines Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Poliomyelitis Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Poliomyelitis Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Poliomyelitis Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Poliomyelitis Vaccines Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Poliomyelitis Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Poliomyelitis Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Poliomyelitis Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Poliomyelitis Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Poliomyelitis Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Poliomyelitis Vaccines Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Poliomyelitis Vaccines Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Poliomyelitis Vaccines Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Poliomyelitis Vaccines Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Sanofi Basic Information, Poliomyelitis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. Sanofi Poliomyelitis Vaccines Product Portfolios and Specifications
Table 80. Sanofi Poliomyelitis Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 81. Sanofi Main Business
Table 82. Sanofi Latest Developments
Table 83. GSK Basic Information, Poliomyelitis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. GSK Poliomyelitis Vaccines Product Portfolios and Specifications
Table 85. GSK Poliomyelitis Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 86. GSK Main Business
Table 87. GSK Latest Developments
Table 88. Bibcol Basic Information, Poliomyelitis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. Bibcol Poliomyelitis Vaccines Product Portfolios and Specifications
Table 90. Bibcol Poliomyelitis Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 91. Bibcol Main Business
Table 92. Bibcol Latest Developments
Table 93. Serum Institute Basic Information, Poliomyelitis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. Serum Institute Poliomyelitis Vaccines Product Portfolios and Specifications
Table 95. Serum Institute Poliomyelitis Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 96. Serum Institute Main Business
Table 97. Serum Institute Latest Developments
Table 98. Tiantan Biological Basic Information, Poliomyelitis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. Tiantan Biological Poliomyelitis Vaccines Product Portfolios and Specifications
Table 100. Tiantan Biological Poliomyelitis Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 101. Tiantan Biological Main Business
Table 102. Tiantan Biological Latest Developments
Table 103. IMBCA Basic Information, Poliomyelitis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. IMBCA Poliomyelitis Vaccines Product Portfolios and Specifications
Table 105. IMBCA Poliomyelitis Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 106. IMBCA Main Business
Table 107. IMBCA Latest Developments
Table 108. Panacea Biotec Ltd Basic Information, Poliomyelitis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 109. Panacea Biotec Ltd Poliomyelitis Vaccines Product Portfolios and Specifications
Table 110. Panacea Biotec Ltd Poliomyelitis Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 111. Panacea Biotec Ltd Main Business
Table 112. Panacea Biotec Ltd Latest Developments
Table 113. Bio-Med Basic Information, Poliomyelitis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. Bio-Med Poliomyelitis Vaccines Product Portfolios and Specifications
Table 115. Bio-Med Poliomyelitis Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 116. Bio-Med Main Business
Table 117. Bio-Med Latest Developments
Table 118. Halfkin Bio-Pharmaceuticals Basic Information, Poliomyelitis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Product Portfolios and Specifications
Table 120. Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 121. Halfkin Bio-Pharmaceuticals Main Business
Table 122. Halfkin Bio-Pharmaceuticals Latest Developments
Table 1. Poliomyelitis Vaccines Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Poliomyelitis Vaccines Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of IPV
Table 4. Major Players of OPV
Table 5. Global Poliomyelitis Vaccines Sales by Type (2018-2023) & (K Units)
Table 6. Global Poliomyelitis Vaccines Sales Market Share by Type (2018-2023)
Table 7. Global Poliomyelitis Vaccines Revenue by Type (2018-2023) & ($ million)
Table 8. Global Poliomyelitis Vaccines Revenue Market Share by Type (2018-2023)
Table 9. Global Poliomyelitis Vaccines Sale Price by Type (2018-2023) & (USD/Unit)
Table 10. Global Poliomyelitis Vaccines Sales by Application (2018-2023) & (K Units)
Table 11. Global Poliomyelitis Vaccines Sales Market Share by Application (2018-2023)
Table 12. Global Poliomyelitis Vaccines Revenue by Application (2018-2023)
Table 13. Global Poliomyelitis Vaccines Revenue Market Share by Application (2018-2023)
Table 14. Global Poliomyelitis Vaccines Sale Price by Application (2018-2023) & (USD/Unit)
Table 15. Global Poliomyelitis Vaccines Sales by Company (2018-2023) & (K Units)
Table 16. Global Poliomyelitis Vaccines Sales Market Share by Company (2018-2023)
Table 17. Global Poliomyelitis Vaccines Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Poliomyelitis Vaccines Revenue Market Share by Company (2018-2023)
Table 19. Global Poliomyelitis Vaccines Sale Price by Company (2018-2023) & (USD/Unit)
Table 20. Key Manufacturers Poliomyelitis Vaccines Producing Area Distribution and Sales Area
Table 21. Players Poliomyelitis Vaccines Products Offered
Table 22. Poliomyelitis Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Poliomyelitis Vaccines Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Poliomyelitis Vaccines Sales Market Share Geographic Region (2018-2023)
Table 27. Global Poliomyelitis Vaccines Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Poliomyelitis Vaccines Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Poliomyelitis Vaccines Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Poliomyelitis Vaccines Sales Market Share by Country/Region (2018-2023)
Table 31. Global Poliomyelitis Vaccines Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Poliomyelitis Vaccines Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Poliomyelitis Vaccines Sales by Country (2018-2023) & (K Units)
Table 34. Americas Poliomyelitis Vaccines Sales Market Share by Country (2018-2023)
Table 35. Americas Poliomyelitis Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Poliomyelitis Vaccines Revenue Market Share by Country (2018-2023)
Table 37. Americas Poliomyelitis Vaccines Sales by Type (2018-2023) & (K Units)
Table 38. Americas Poliomyelitis Vaccines Sales by Application (2018-2023) & (K Units)
Table 39. APAC Poliomyelitis Vaccines Sales by Region (2018-2023) & (K Units)
Table 40. APAC Poliomyelitis Vaccines Sales Market Share by Region (2018-2023)
Table 41. APAC Poliomyelitis Vaccines Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Poliomyelitis Vaccines Revenue Market Share by Region (2018-2023)
Table 43. APAC Poliomyelitis Vaccines Sales by Type (2018-2023) & (K Units)
Table 44. APAC Poliomyelitis Vaccines Sales by Application (2018-2023) & (K Units)
Table 45. Europe Poliomyelitis Vaccines Sales by Country (2018-2023) & (K Units)
Table 46. Europe Poliomyelitis Vaccines Sales Market Share by Country (2018-2023)
Table 47. Europe Poliomyelitis Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Poliomyelitis Vaccines Revenue Market Share by Country (2018-2023)
Table 49. Europe Poliomyelitis Vaccines Sales by Type (2018-2023) & (K Units)
Table 50. Europe Poliomyelitis Vaccines Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Poliomyelitis Vaccines Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Poliomyelitis Vaccines Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Poliomyelitis Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Poliomyelitis Vaccines Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Poliomyelitis Vaccines Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Poliomyelitis Vaccines Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Poliomyelitis Vaccines
Table 58. Key Market Challenges & Risks of Poliomyelitis Vaccines
Table 59. Key Industry Trends of Poliomyelitis Vaccines
Table 60. Poliomyelitis Vaccines Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Poliomyelitis Vaccines Distributors List
Table 63. Poliomyelitis Vaccines Customer List
Table 64. Global Poliomyelitis Vaccines Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Poliomyelitis Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Poliomyelitis Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Poliomyelitis Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Poliomyelitis Vaccines Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Poliomyelitis Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Poliomyelitis Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Poliomyelitis Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Poliomyelitis Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Poliomyelitis Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Poliomyelitis Vaccines Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Poliomyelitis Vaccines Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Poliomyelitis Vaccines Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Poliomyelitis Vaccines Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Sanofi Basic Information, Poliomyelitis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. Sanofi Poliomyelitis Vaccines Product Portfolios and Specifications
Table 80. Sanofi Poliomyelitis Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 81. Sanofi Main Business
Table 82. Sanofi Latest Developments
Table 83. GSK Basic Information, Poliomyelitis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. GSK Poliomyelitis Vaccines Product Portfolios and Specifications
Table 85. GSK Poliomyelitis Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 86. GSK Main Business
Table 87. GSK Latest Developments
Table 88. Bibcol Basic Information, Poliomyelitis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. Bibcol Poliomyelitis Vaccines Product Portfolios and Specifications
Table 90. Bibcol Poliomyelitis Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 91. Bibcol Main Business
Table 92. Bibcol Latest Developments
Table 93. Serum Institute Basic Information, Poliomyelitis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. Serum Institute Poliomyelitis Vaccines Product Portfolios and Specifications
Table 95. Serum Institute Poliomyelitis Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 96. Serum Institute Main Business
Table 97. Serum Institute Latest Developments
Table 98. Tiantan Biological Basic Information, Poliomyelitis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. Tiantan Biological Poliomyelitis Vaccines Product Portfolios and Specifications
Table 100. Tiantan Biological Poliomyelitis Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 101. Tiantan Biological Main Business
Table 102. Tiantan Biological Latest Developments
Table 103. IMBCA Basic Information, Poliomyelitis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. IMBCA Poliomyelitis Vaccines Product Portfolios and Specifications
Table 105. IMBCA Poliomyelitis Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 106. IMBCA Main Business
Table 107. IMBCA Latest Developments
Table 108. Panacea Biotec Ltd Basic Information, Poliomyelitis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 109. Panacea Biotec Ltd Poliomyelitis Vaccines Product Portfolios and Specifications
Table 110. Panacea Biotec Ltd Poliomyelitis Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 111. Panacea Biotec Ltd Main Business
Table 112. Panacea Biotec Ltd Latest Developments
Table 113. Bio-Med Basic Information, Poliomyelitis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. Bio-Med Poliomyelitis Vaccines Product Portfolios and Specifications
Table 115. Bio-Med Poliomyelitis Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 116. Bio-Med Main Business
Table 117. Bio-Med Latest Developments
Table 118. Halfkin Bio-Pharmaceuticals Basic Information, Poliomyelitis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Product Portfolios and Specifications
Table 120. Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 121. Halfkin Bio-Pharmaceuticals Main Business
Table 122. Halfkin Bio-Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Poliomyelitis Vaccines
Figure 2. Poliomyelitis Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Poliomyelitis Vaccines Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Poliomyelitis Vaccines Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Poliomyelitis Vaccines Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of IPV
Figure 10. Product Picture of OPV
Figure 11. Global Poliomyelitis Vaccines Sales Market Share by Type in 2022
Figure 12. Global Poliomyelitis Vaccines Revenue Market Share by Type (2018-2023)
Figure 13. Poliomyelitis Vaccines Consumed in Research & Academic Laboratories
Figure 14. Global Poliomyelitis Vaccines Market: Research & Academic Laboratories (2018-2023) & (K Units)
Figure 15. Poliomyelitis Vaccines Consumed in Pharmaceutical & Biotechnology Companies
Figure 16. Global Poliomyelitis Vaccines Market: Pharmaceutical & Biotechnology Companies (2018-2023) & (K Units)
Figure 17. Poliomyelitis Vaccines Consumed in Others
Figure 18. Global Poliomyelitis Vaccines Market: Others (2018-2023) & (K Units)
Figure 19. Global Poliomyelitis Vaccines Sales Market Share by Application (2022)
Figure 20. Global Poliomyelitis Vaccines Revenue Market Share by Application in 2022
Figure 21. Poliomyelitis Vaccines Sales Market by Company in 2022 (K Units)
Figure 22. Global Poliomyelitis Vaccines Sales Market Share by Company in 2022
Figure 23. Poliomyelitis Vaccines Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Poliomyelitis Vaccines Revenue Market Share by Company in 2022
Figure 25. Global Poliomyelitis Vaccines Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Poliomyelitis Vaccines Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Poliomyelitis Vaccines Sales 2018-2023 (K Units)
Figure 28. Americas Poliomyelitis Vaccines Revenue 2018-2023 ($ Millions)
Figure 29. APAC Poliomyelitis Vaccines Sales 2018-2023 (K Units)
Figure 30. APAC Poliomyelitis Vaccines Revenue 2018-2023 ($ Millions)
Figure 31. Europe Poliomyelitis Vaccines Sales 2018-2023 (K Units)
Figure 32. Europe Poliomyelitis Vaccines Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Poliomyelitis Vaccines Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Poliomyelitis Vaccines Revenue 2018-2023 ($ Millions)
Figure 35. Americas Poliomyelitis Vaccines Sales Market Share by Country in 2022
Figure 36. Americas Poliomyelitis Vaccines Revenue Market Share by Country in 2022
Figure 37. Americas Poliomyelitis Vaccines Sales Market Share by Type (2018-2023)
Figure 38. Americas Poliomyelitis Vaccines Sales Market Share by Application (2018-2023)
Figure 39. United States Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Poliomyelitis Vaccines Sales Market Share by Region in 2022
Figure 44. APAC Poliomyelitis Vaccines Revenue Market Share by Regions in 2022
Figure 45. APAC Poliomyelitis Vaccines Sales Market Share by Type (2018-2023)
Figure 46. APAC Poliomyelitis Vaccines Sales Market Share by Application (2018-2023)
Figure 47. China Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Poliomyelitis Vaccines Sales Market Share by Country in 2022
Figure 55. Europe Poliomyelitis Vaccines Revenue Market Share by Country in 2022
Figure 56. Europe Poliomyelitis Vaccines Sales Market Share by Type (2018-2023)
Figure 57. Europe Poliomyelitis Vaccines Sales Market Share by Application (2018-2023)
Figure 58. Germany Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Poliomyelitis Vaccines Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Poliomyelitis Vaccines Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Poliomyelitis Vaccines Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Poliomyelitis Vaccines Sales Market Share by Application (2018-2023)
Figure 67. Egypt Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Poliomyelitis Vaccines in 2022
Figure 73. Manufacturing Process Analysis of Poliomyelitis Vaccines
Figure 74. Industry Chain Structure of Poliomyelitis Vaccines
Figure 75. Channels of Distribution
Figure 76. Global Poliomyelitis Vaccines Sales Market Forecast by Region (2024-2029)
Figure 77. Global Poliomyelitis Vaccines Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Poliomyelitis Vaccines Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Poliomyelitis Vaccines Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Poliomyelitis Vaccines Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Poliomyelitis Vaccines Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Poliomyelitis Vaccines
Figure 2. Poliomyelitis Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Poliomyelitis Vaccines Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Poliomyelitis Vaccines Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Poliomyelitis Vaccines Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of IPV
Figure 10. Product Picture of OPV
Figure 11. Global Poliomyelitis Vaccines Sales Market Share by Type in 2022
Figure 12. Global Poliomyelitis Vaccines Revenue Market Share by Type (2018-2023)
Figure 13. Poliomyelitis Vaccines Consumed in Research & Academic Laboratories
Figure 14. Global Poliomyelitis Vaccines Market: Research & Academic Laboratories (2018-2023) & (K Units)
Figure 15. Poliomyelitis Vaccines Consumed in Pharmaceutical & Biotechnology Companies
Figure 16. Global Poliomyelitis Vaccines Market: Pharmaceutical & Biotechnology Companies (2018-2023) & (K Units)
Figure 17. Poliomyelitis Vaccines Consumed in Others
Figure 18. Global Poliomyelitis Vaccines Market: Others (2018-2023) & (K Units)
Figure 19. Global Poliomyelitis Vaccines Sales Market Share by Application (2022)
Figure 20. Global Poliomyelitis Vaccines Revenue Market Share by Application in 2022
Figure 21. Poliomyelitis Vaccines Sales Market by Company in 2022 (K Units)
Figure 22. Global Poliomyelitis Vaccines Sales Market Share by Company in 2022
Figure 23. Poliomyelitis Vaccines Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Poliomyelitis Vaccines Revenue Market Share by Company in 2022
Figure 25. Global Poliomyelitis Vaccines Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Poliomyelitis Vaccines Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Poliomyelitis Vaccines Sales 2018-2023 (K Units)
Figure 28. Americas Poliomyelitis Vaccines Revenue 2018-2023 ($ Millions)
Figure 29. APAC Poliomyelitis Vaccines Sales 2018-2023 (K Units)
Figure 30. APAC Poliomyelitis Vaccines Revenue 2018-2023 ($ Millions)
Figure 31. Europe Poliomyelitis Vaccines Sales 2018-2023 (K Units)
Figure 32. Europe Poliomyelitis Vaccines Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Poliomyelitis Vaccines Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Poliomyelitis Vaccines Revenue 2018-2023 ($ Millions)
Figure 35. Americas Poliomyelitis Vaccines Sales Market Share by Country in 2022
Figure 36. Americas Poliomyelitis Vaccines Revenue Market Share by Country in 2022
Figure 37. Americas Poliomyelitis Vaccines Sales Market Share by Type (2018-2023)
Figure 38. Americas Poliomyelitis Vaccines Sales Market Share by Application (2018-2023)
Figure 39. United States Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Poliomyelitis Vaccines Sales Market Share by Region in 2022
Figure 44. APAC Poliomyelitis Vaccines Revenue Market Share by Regions in 2022
Figure 45. APAC Poliomyelitis Vaccines Sales Market Share by Type (2018-2023)
Figure 46. APAC Poliomyelitis Vaccines Sales Market Share by Application (2018-2023)
Figure 47. China Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Poliomyelitis Vaccines Sales Market Share by Country in 2022
Figure 55. Europe Poliomyelitis Vaccines Revenue Market Share by Country in 2022
Figure 56. Europe Poliomyelitis Vaccines Sales Market Share by Type (2018-2023)
Figure 57. Europe Poliomyelitis Vaccines Sales Market Share by Application (2018-2023)
Figure 58. Germany Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Poliomyelitis Vaccines Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Poliomyelitis Vaccines Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Poliomyelitis Vaccines Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Poliomyelitis Vaccines Sales Market Share by Application (2018-2023)
Figure 67. Egypt Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Poliomyelitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Poliomyelitis Vaccines in 2022
Figure 73. Manufacturing Process Analysis of Poliomyelitis Vaccines
Figure 74. Industry Chain Structure of Poliomyelitis Vaccines
Figure 75. Channels of Distribution
Figure 76. Global Poliomyelitis Vaccines Sales Market Forecast by Region (2024-2029)
Figure 77. Global Poliomyelitis Vaccines Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Poliomyelitis Vaccines Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Poliomyelitis Vaccines Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Poliomyelitis Vaccines Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Poliomyelitis Vaccines Revenue Market Share Forecast by Application (2024-2029)
